239 related articles for article (PubMed ID: 27996211)
21. Glycogen synthase kinase 3β in the basolateral amygdala is critical for the reconsolidation of cocaine reward memory.
Wu P; Xue YX; Ding ZB; Xue LF; Xu CM; Lu L
J Neurochem; 2011 Jul; 118(1):113-25. PubMed ID: 21592120
[TBL] [Abstract][Full Text] [Related]
22. Constitutive activity of dopamine receptor type 1 (D1R) increases CaV2.2 currents in PFC neurons.
McCarthy CI; Chou-Freed C; Rodríguez SS; Yaneff A; Davio C; Raingo J
J Gen Physiol; 2020 May; 152(5):. PubMed ID: 32259196
[TBL] [Abstract][Full Text] [Related]
23. Mitogen-activated protein kinase upregulation reduces renal D1 receptor affinity and G-protein coupling in obese rats.
Banday AA; Fazili FR; Marwaha A; Lokhandwala MF
Kidney Int; 2007 Mar; 71(5):397-406. PubMed ID: 17191082
[TBL] [Abstract][Full Text] [Related]
24. A novel dopamine D1 receptor agonist excites delay-dependent working memory-related neuronal firing in primate dorsolateral prefrontal cortex.
Wang M; Datta D; Enwright J; Galvin V; Yang ST; Paspalas C; Kozak R; Gray DL; Lewis DA; Arnsten AFT
Neuropharmacology; 2019 May; 150():46-58. PubMed ID: 30858103
[TBL] [Abstract][Full Text] [Related]
25. Impaired β-arrestin recruitment and reduced desensitization by non-catechol agonists of the D1 dopamine receptor.
Gray DL; Allen JA; Mente S; O'Connor RE; DeMarco GJ; Efremov I; Tierney P; Volfson D; Davoren J; Guilmette E; Salafia M; Kozak R; Ehlers MD
Nat Commun; 2018 Feb; 9(1):674. PubMed ID: 29445200
[TBL] [Abstract][Full Text] [Related]
26. Hippocampal and prefrontal dopamine D1/5 receptor involvement in the memory-enhancing effect of reboxetine.
De Bundel D; Femenía T; DuPont CM; Konradsson-Geuken Å; Feltmann K; Schilström B; Lindskog M
Int J Neuropsychopharmacol; 2013 Oct; 16(9):2041-51. PubMed ID: 23672849
[TBL] [Abstract][Full Text] [Related]
27. Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine.
Mouri A; Noda Y; Noda A; Nakamura T; Tokura T; Yura Y; Nitta A; Furukawa H; Nabeshima T
Mol Pharmacol; 2007 Jun; 71(6):1598-609. PubMed ID: 17344353
[TBL] [Abstract][Full Text] [Related]
28. Group II metabotropic glutamate receptor agonist ameliorates MK801-induced dysfunction of NMDA receptors via the Akt/GSK-3β pathway in adult rat prefrontal cortex.
Xi D; Li YC; Snyder MA; Gao RY; Adelman AE; Zhang W; Shumsky JS; Gao WJ
Neuropsychopharmacology; 2011 May; 36(6):1260-74. PubMed ID: 21326193
[TBL] [Abstract][Full Text] [Related]
29. Regulation of dopamine D-receptor activation in vivo by protein phosphatase 2B (calcineurin).
Adlersberg M; Hsiung SC; Glickstein SB; Liu KP; Tamir H; Schmauss C
J Neurochem; 2004 Aug; 90(4):865-73. PubMed ID: 15287892
[TBL] [Abstract][Full Text] [Related]
30. Functional selectivity of allosteric interactions within G protein-coupled receptor oligomers: the dopamine D1-D3 receptor heterotetramer.
Guitart X; Navarro G; Moreno E; Yano H; Cai NS; Sánchez-Soto M; Kumar-Barodia S; Naidu YT; Mallol J; Cortés A; Lluís C; Canela EI; Casadó V; McCormick PJ; Ferré S
Mol Pharmacol; 2014 Oct; 86(4):417-29. PubMed ID: 25097189
[TBL] [Abstract][Full Text] [Related]
31. Insulin receptor deficits in schizophrenia and in cellular and animal models of insulin receptor dysfunction.
Zhao Z; Ksiezak-Reding H; Riggio S; Haroutunian V; Pasinetti GM
Schizophr Res; 2006 May; 84(1):1-14. PubMed ID: 16581231
[TBL] [Abstract][Full Text] [Related]
32. Characterization of dopamine D
Egusquiza I; Munarriz-Cuezva E; Segarra R; González-Maeso J; Callado LF; Meana JJ; Diez-Alarcia R
Pharmacol Rep; 2021 Aug; 73(4):1136-1146. PubMed ID: 34196951
[TBL] [Abstract][Full Text] [Related]
33. Constellation of HCN channels and cAMP regulating proteins in dendritic spines of the primate prefrontal cortex: potential substrate for working memory deficits in schizophrenia.
Paspalas CD; Wang M; Arnsten AF
Cereb Cortex; 2013 Jul; 23(7):1643-54. PubMed ID: 22693343
[TBL] [Abstract][Full Text] [Related]
34. The effect of a full agonist/antagonist of the D1 receptor on locomotor activity, sensorimotor gating and cognitive function in dizocilpine-treated rats.
Bubenikova-Valesova V; Svoboda J; Horacek J; Vales K
Int J Neuropsychopharmacol; 2009 Aug; 12(7):873-83. PubMed ID: 19154630
[TBL] [Abstract][Full Text] [Related]
35. Desensitization of human renal D1 dopamine receptors by G protein-coupled receptor kinase 4.
Watanabe H; Xu J; Bengra C; Jose PA; Felder RA
Kidney Int; 2002 Sep; 62(3):790-8. PubMed ID: 12164861
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of glycogen synthase kinase-3β by lithium chloride suppresses 6-hydroxydopamine-induced inflammatory response in primary cultured astrocytes.
Wang HM; Zhang T; Li Q; Huang JK; Chen RF; Sun XJ
Neurochem Int; 2013 Nov; 63(5):345-53. PubMed ID: 23871716
[TBL] [Abstract][Full Text] [Related]
37. Hyperdopaminergic modulation of inhibitory transmission is dependent on GSK-3β signaling-mediated trafficking of GABAA receptors.
Li YC; Wang MJ; Gao WJ
J Neurochem; 2012 Jul; 122(2):308-20. PubMed ID: 22676038
[TBL] [Abstract][Full Text] [Related]
38. Diminished natriuretic response to dopamine in old rats is due to an impaired D1-like receptor-signaling pathway.
Beheray S; Kansra V; Hussain T; Lokhandwala MF
Kidney Int; 2000 Aug; 58(2):712-20. PubMed ID: 10916094
[TBL] [Abstract][Full Text] [Related]
39. Structure-Functional Selectivity Relationship Studies on A-86929 Analogs and Small Aryl Fragments toward the Discovery of Biased Dopamine D1 Receptor Agonists.
Li H; Mirabel R; Zimmerman J; Ghiviriga I; Phidd DK; Horenstein N; Urs NM
ACS Chem Neurosci; 2022 Jun; 13(12):1818-1831. PubMed ID: 35658399
[TBL] [Abstract][Full Text] [Related]
40. Reduced GSK-3beta mRNA levels in postmortem dorsolateral prefrontal cortex of schizophrenic patients.
Kozlovsky N; Shanon-Weickert C; Tomaskovic-Crook E; Kleinman JE; Belmaker RH; Agam G
J Neural Transm (Vienna); 2004 Dec; 111(12):1583-92. PubMed ID: 15565492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
